- Home
- ANL vs OFS Comparison
ANL vs OFS Comparison
Compare ANL & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ANL | OFS |
|---|---|---|
| Founded | 2004 | 2001 |
| Country | Cayman Islands | United States |
| Employees | N/A | 53 |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.5M | 57.2M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANL | OFS |
|---|---|---|
| Price | $8.04 | $3.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 215.2K | 79.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 19.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.44 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $3.43 |
| 52 Week High | $12.09 | $9.80 |
Technical Indicators
Market Signals| Indicator | ANL | OFS |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 22.37 |
| Support Level | $1.37 | N/A |
| Resistance Level | $9.98 | $5.33 |
| Average True Range (ATR) | 1.05 | 0.18 |
| MACD | -0.30 | -0.06 |
| Stochastic Oscillator | 29.59 | 2.40 |
Price Performance
Historical ComparisonAbout ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.